Literature DB >> 26400551

A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER).

T Papalia1, R Lappano, A Barattucci, A Pisano, G Bruno, M F Santolla, S Campagna, P De Marco, F Puntoriero, E M De Francesco, C Rosano, M Maggiolini, P Bonaccorsi.   

Abstract

We report the rational design, based on docking simulations, and synthesis of the first fluorescent and selective probe of GPER for bioimaging purposes and functional dissecting studies. It has been conceived as a Bodipy derivative and obtained by accessible and direct synthesis. Its optical properties have been measured in different solvents, showing insensitivity to their polarity. Its binding to GPER was achieved by competition assays with [3H]E2 and [5,6-3H] nicotinic acid in ER-negative and GPER-positive SkBr3 breast cancer cells. SkBr3 cells, transfected with a GPER expression vector containing a FLAG tag, were used to confirm that the fluorophore binds to GPER in a specific manner.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26400551     DOI: 10.1039/c5ob01827g

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  5 in total

1.  A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice.

Authors:  Chelsea DeLeon; Helen H Wang; Joseph Gunn; McKenna Wilhelm; Aidan Cole; Stacy Arnett; David Q-H Wang; Christopher K Arnatt
Journal:  J Lipid Res       Date:  2020-03-03       Impact factor: 5.922

Review 2.  Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands.

Authors:  Camillo Rosano; Marco Ponassi; Maria Francesca Santolla; Assunta Pisano; Lamberto Felli; Adele Vivacqua; Marcello Maggiolini; Rosamaria Lappano
Journal:  AAPS J       Date:  2015-11-16       Impact factor: 4.009

3.  A Series of Indole-Thiazole Derivatives Act as GPER Agonists and Inhibit Breast Cancer Cell Growth.

Authors:  Austin O'Dea; Chelsea Sondergard; Patrick Sweeney; Christopher Kent Arnatt
Journal:  ACS Med Chem Lett       Date:  2018-09-04       Impact factor: 4.345

4.  Linker length in fluorophore-cholesterol conjugates directs phase selectivity and cellular localisation in GUVs and live cells.

Authors:  Darragh O' Connor; Aisling Byrne; Tia E Keyes
Journal:  RSC Adv       Date:  2019-07-23       Impact factor: 4.036

Review 5.  Computational Approaches for the Discovery of GPER Targeting Compounds.

Authors:  Fedora Grande; Maria A Occhiuzzi; Rosamaria Lappano; Francesca Cirillo; Rita Guzzi; Antonio Garofalo; Yves Jacquot; Marcello Maggiolini; Bruno Rizzuti
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-04       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.